Apollo Hospitals Robust Q4 Performance and Strategic Growth Milestones

Apollo Hospitals has reported a strong performance for the quarter ended March 31, 2026, with consolidated revenue reaching ₹6,605 crore, an 18% year-on-year growth. The company achieved a consolidated PAT of ₹529 crore, a 36% growth compared to the same quarter last year. Key highlights include an AAA credit rating from ICRA, a final dividend recommendation of ₹10 per share, and a strategic divestment in its maternity and fertility business.

Strong Financial Growth

For the financial year ended March 31, 2026, Apollo Hospitals recorded a total consolidated revenue of ₹25,229 crore, representing a 16% year-on-year growth. The consolidated EBITDA for the year stood at ₹3,769 crore, a 25% increase, while the consolidated PAT grew by 34% to reach ₹1,942 crore. The board has recommended a final dividend of ₹10 per equity share (200%) for the financial year 2025-26.

Strategic Business Developments

Apollo Health and Lifestyle Limited (AHLL) has entered a strategic transaction with Kids Clinic India Limited (‘Cloudnine’). AHLL will divest its stake in Apollo Specialty Hospitals and Apollo Fertility Centre to Cloudnine at an enterprise value of approximately ₹1,550 crore. This consideration includes a cash component of ₹765 crore and an equity stake of approximately 9.9% in the combined entity, positioning Apollo as the largest non-financial shareholder in the platform.

Expansion and Operational Highlights

The company continues to expand its footprint with the successful commissioning of a 400-bedded smart hospital in the Financial District, Hyderabad, and the launch of a new 270-bed facility in Sonarpur, Kolkata. As of March 31, 2026, the group operates 8,131 beds with an overall hospital occupancy rate of 68%. Furthermore, the company reported that its digital platform, Apollo 24/7, achieved a GMV of ₹2,037 crore for the full financial year.

Leadership and Governance

The Board of Directors has approved the re-appointment of Dr. Prathap C Reddy as Executive Chairman for a period of two years effective June 25, 2026. Additionally, the proposal for the merger of Apollo Hospitals North Limited into the holding company was approved to consolidate operations and optimize costs. The annual general meeting is scheduled for August 25, 2026, with the record date for dividends set for August 14, 2026.

Source: BSE

Previous Article

Action Construction Equipment Limited Strong Financial Performance for FY 2025-26

Next Article

Honeywell Automation India Limited 42nd Annual General Meeting and Dividend Announcement